- Investopedia•2 months ago
Genetic Technologies expects to raise more than $6 million through an offering of its American Depositary Shares.
- Marketwired•2 months ago
Genetic Technologies Limited , a molecular diagnostics company and provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for sporadic breast cancer, today announced that ...
- 24/7 Wall St.•2 months ago
Shares of Genetic Technologies practically doubled in Tuesday's session after the company announced the signing of an exclusive worldwide license agreement with the University of Melbourne.
GTG.AX : Summary for GENE TECH FPO - Yahoo Finance
Genetic Technologies Limited (GTG.AX)
ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
|Day's Range||0.01 - 0.01|
|52 Week Range||0.01 - 0.02|
|PE Ratio (TTM)||-2.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|